US-Rx Care urges employers to adopt rigorous contract-level scrutiny when selecting Pharmacy Benefit Managers
Executive summary: US-Rx Care issued a list of ten critical questions for employers to use when vetting transparent Pharmacy Benefit Managers (PBMs). It addresses the gap between PBM 'transparency' marketing and actual cost-containment results, focusing on fiduciary responsibility and audit rights.
Who is involved: US-Rx Care, employers, benefits providers, and Pharmacy Benefit Managers (PBMs).
Likely next: Increased pressure on PBMs to provide contract-level data and more sophisticated auditing by corporate benefits departments.
US-Rx Care has released a guidance framework for employers to evaluate PBM transparency beyond surface-level claims. The advisory emphasizes the necessity of testing for fiduciary duties, pricing structures, and data ownership at the contract level. This move follows a growing trend of stakeholders demanding more substantive accountability in pharmacy benefit management.
What's next — scenarios
Base: Increased scrutiny on contract terms (60%)
Employers demand more granular audit rights and data ownership clauses in PBM contracts.
- Adoption of the 10-question framework by major benefits consultants
Upside: Shift toward fiduciary-first PBM models (25%)
Market share shifts from traditional PBMs to transparent models that prioritize direct pass-through pricing.
- Evidence of significant cost reduction in pilot transparency programs
Downside: Superficial compliance (15%)
PBMs implement 'transparency' features that do not materially impact the total cost of prescription drugs.
- Stagnant pharmacy trend costs despite new contract models
What to watch
- Quarterly pharmacy benefit trend reports from large employer groups
- State-level legislative updates regarding PBM fiduciary duties
- Changes in PBM contract standardization in the US
Timeline
- — Before Choosing a Transparent PBM, Employers Should Ask These 10 Questions (PR Newswire)
- — SHARx Warns PBM Rebate Reform May Move Money Without Lowering Employer Costs (PR Newswire)
- — Good Employers Keep Choosing the Wrong PBM Because They Start With the Wrong Metrics (PR Newswire)
Analysis — what this means
Sectors affected
- Pharmacy Benefit Management (PBM)
- Corporate Benefits & Insurance
- Healthcare Administration
Regulatory implications
- Increased state-level oversight of PBM fiduciary responsibility
Historical parallels
- SHARx warnings on rebate reform limitations (2026)
- US-Rx Care warnings on metric-driven selection errors (2026)
Key entities
Sources
- Before Choosing a Transparent PBM, Employers Should Ask These 10 Questions — PR Newswire
- SHARx Warns PBM Rebate Reform May Move Money Without Lowering Employer Costs — PR Newswire
- Good Employers Keep Choosing the Wrong PBM Because They Start With the Wrong Metrics — PR Newswire